Page 58 - XXIV Monografías en Esclerosis Múltiple

FUNDAMENTOS INMUNOLÓGICOS DEL TRATAMIENTO DE LA ESCLEROSIS MÚLTIPLE
58
BIBLIOGRAFÍA
1. Correale J, McMillan M, McCarthy K, Le T, Weiner LP. Isolation and characterization of auto- reactive proteolipid protein-peptide specific T-cell clones from multiple sclerosis patients. Neu- rology. 1995;45(7):1370-8.
2. Farez MF, Quintana FJ, Gandhi R, Izquierdo G, Lucas M, Weiner HL. Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE. Nat Immunol. 2009 Sep 16;10(9):958-64.
3. Reich DS, Lucchinetti CF, Calabresi PA. Multiple Sclerosis. N Engl J Med. 2018;378(2):169-80. 4. Miller SD, Eagar TN. Functional role of epitope spreading in the chronic pathogenesis of autoim-
mune and virus-induced demyelinating diseases. Adv Exp Med Biol. 2001;490:99-107.
5. Archelos JJ, Previtali SC, Hartung HP. The role of integrins in immune-mediated diseases of the
nervous system. Trends Neurosci. 1999 Jan;22(1):30-8. Review.
6. Correale J, Villa A. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic
targeting. Autoimmunity. 2007 Jan 7;40(2):148-60.
7. Ransohoff RM, Kivisäkk P, Kidd G. Three or more routes for leukocyte migration into the central
nervous system. Nat Rev Immunol. 2003 Jul 1;3(7):569-81.
8. Becher B, Prat A, Antel JP. Brain-immune connection: immuno-regulatory properties of CNS-res-
ident cells. Glia. 2000 Feb 15;29(4):293-304.
9. Patel DD, Kuchroo VK. Th17 Cell Pathway in Human Immunity: Lessons from Genetics and
Therapeutic Interventions. Immunity. 2015 Dec;43(6):1040-51.
10. Sospedra M, Martin R. Immunology of multiple sclerosis. Annu Rev Immunol. 2005;23(1):683-747.
11. McFarland HF, Martin R. Multiple sclerosis: a complicated picture of autoimmunity. Nat Immu-
nol. 2007 Sep 1;8(9):913-9.
12. Franciotta D, Salvetti M, Lolli F, Serafini B, Aloisi F. B cells and multiple sclerosis. Lancet Neurol.
2008 Sep;7(9):852-8.
13. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A, et al. Recapitulation of B cell
differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci
U S A. 2004 Jul 27;101(30):11064-9.
14. Brosnan CF, Battistini L, Raine CS, Dickson DW, Casadevall A, Lee SC. Reactive nitrogen inter-
mediates in human neuropathology: an overview. Dev Neurosci. 1994;16(3-4):152-61.
15. Werner P, Pitt D, Raine CS. Multiple sclerosis: altered glutamate homeostasis in lesions correlates
with oligodendrocyre and axonal damage. Ann Neurol. 2001;50(2):169-80.
16. Correale J, Gaitán MI, Ysrraelit MC, Fiol MP. Progressive multiple sclerosis: from pathogenic
mechanisms to treatment. Brain. 2017 Mar 1;140(3):527-46.
17. Peterson JW, Bö L, Mörk S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and
reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol. 2001 Sep;50(3):389-400.
18. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain. 2009
May;132(5):1175-89.
19. Meuth SG, Simon OJ, Grimm A, Melzer N, Herrmann AM, Spitzer P, et al. CNS inflammation
and neuronal degeneration is aggravated by impaired CD200-CD200R-mediated macrophage si-
lencing. J Neuroimmunol. 2008 Feb;194(1-2):62-9.
20. Barnett MH, Prineas JW. Relapsing and remitting multiple sclerosis. Ann Neurol. 2004;55(4):458-68.